Given that sEH deletion and 12,13-EpOME treatment increased the proliferation of matrix cells, sEH inhibition could serve as a therapeutic option for treatment of hair loss at early stages of cancer therapy by prolonging the anagen stage. This evidence concerns the gene EPHX2 and alopecia.